{ "@context": "https://schema.org", "@graph": [ { "@type": "LegalCase", "@id": "case-7782", "postId": 7782, "name": "agilon health, inc.", "description": "Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (\u201cagilon\u201d or the \u201cCompany\u201d) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved, given material industry headwinds of which they were aware; (2) Defendants materially overstated the immediate positive financial impact from \u201cstrategic actions\u201d taken by agilon to reduce risk; and (3) as a result, defendants\u2019 statements about agilon\u2019s business, operations, and prospects were materially false and/or misleading at all times. When the true details entered the market, the lawsuit claims that investors suffered damages. Lead Plaintiff Deadline: March 2, 2026 \u00a0Call\u00a0Partner Josh Wilson\u00a0at\u00a0877-247-4292\u00a0or\u00a0212-983-9330 (Ext. 1310) Or\u00a0submit your information below\u00a0to learn about your rights.", "identifier": "AGL", "legal": { "court": "", "jurisdiction": "" }, "classPeriod": { "start": "02/26/2025", "end": "08/04/2025" }, "leadPlaintiffDeadline": "03/02/2026", "caseStatus": { "name": "", "slug": "" }, "practiceArea": { "name": "Securities Litigation", "slug": "securities-litigation" }, "url": "https://faruqilaw.com/case/agilon-health-inc/", "canonicalUrl": "https://faruqilaw.com/case/agilon-health-inc/", "datePublished": "2026-01-05T16:01:36+00:00", "dateModified": "2026-01-05T16:05:59+00:00", "associatedOrganization": { "@id": "case-7782-org" }, "legalService": { "@id": "case-7782-legalservice" }, "hasPart": [ { "@id": "case-7782-faq" }, { "@id": "case-7782-press-list" } ], "legalRepresentation": [ { "@id": "case-7782-attorney-516" }, { "@id": "case-7782-attorney-506" } ] }, { "@type": "Organization", "@id": "case-7782-org", "name": "agilon health, inc.", "identifier": "AGL", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg" }, { "@type": "LegalService", "@id": "case-7782-legalservice", "name": "Faruqi & Faruqi, LLP", "url": "https://faruqilaw.com/", "telephone": "+1-212-983-9330", "logo": "https://faruqilaw.com/wp-content/uploads/2025/05/logo.svg", "address": { "@type": "PostalAddress", "streetAddress": "685 3rd Ave 26th Floor", "addressLocality": "New York", "postalCode": "10017", "addressRegion": "NY", "addressCountry": "US" }, "sameAs": [ "https://faruqilaw.com/", "https://maps.google.com/?cid=3247549158190754383" ] }, { "@type": "Person", "@id": "case-7782-attorney-516", "name": "James M. Wilson, Jr.", "worksFor": { "@id": "case-7782-legalservice" } }, { "@type": "Person", "@id": "case-7782-attorney-506", "name": "Robert W. Killorin", "worksFor": { "@id": "case-7782-legalservice" } } ] }

agilon health, inc.

agilon health, inc.

Join Action
Case Details
Filed On: January 5, 2026
Ticker AGL
Class Period 02/26/2025 - 08/04/2025
Lead Plaintiff Deadline 03/02/2026
Days Left to Seek Plaintiff
54

If you are an agilon health investor who suffered a loss and would like to learn more, you can provide your information below:

Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against agilon health, inc. (“agilon” or the “Company”) (NYSE: AGL) and reminds investors of the March 2, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company.

As detailed below, the complaint alleges that the Company and its executives violated federal securities laws by making false and/or misleading statements and/or failing to disclose that: (1) Defendants recklessly issued guidance for 2025 that they knew or should have known was not going to be achieved, given material industry headwinds of which they were aware; (2) Defendants materially overstated the immediate positive financial impact from “strategic actions” taken by agilon to reduce risk; and (3) as a result, defendants’ statements about agilon’s business, operations, and prospects were materially false and/or misleading at all times. When the true details entered the market, the lawsuit claims that investors suffered damages.

📞 Lead Plaintiff Deadline: March 2, 2026

💻 Call Partner Josh Wilson at 877-247-4292 or 212-983-9330 (Ext. 1310)
Or submit your information below to learn about your rights.

Join Action
agilon health, inc.
1
1
1
1

Accepted file types: xls, xlsx, doc, docx, pdf, jpg, jpeg, png, Max. file size: 50 MB, Max. files: 5.
You may redact account numbers from your uploaded documents.

File name:

File size:

Counsel
James M. Wilson, Jr.
jwilson@faruqilaw.com
Phone (212) 983-9330
Fax (212) 983-9331
Robert W. Killorin
rkillorin@faruqilaw.com
Phone (404) 847-0617
Fax (404) 506-9534
Office
New York
685 Third Avenue 26th Floor New York New York 10017
Phone (212) 983-9330
Fax (212) 983-9331

Our Offices

Our offices are nationwide. If you have any questions about a case or our firm, please contact us.
Send Us a Message
New York
685 Third Avenue 26th Floor
New York New York 10017
(877) 247-4292 / (212) 983-9330
(212) 983-9331
Los Angeles
1901 Avenue of the Stars Suite 1060
Los Angeles California 90067
(424) 256-2884
(424) 256-2885
Atlanta
3565 Piedmont Road NE Building Four, Suite 380
Atlanta Georgia 30305
(404) 847-0617
(404) 506-9534
Philadelphia
1617 JFK Boulevard, Suite 1550 Philadelphia
Pennsylvania 19103
(215) 277-5770
(215) 277-5771